Human Leukocyte Antigen (HLA) and Killer Immunoglobulin-Like Receptors (KIR) in HIV-2 Infection release_brt3af6ixzh4zo7klai6p53idu

by Louis Marie Yindom

Published by The Open University.

2010  

Abstract

In West Africa, the Acquired Immunodeficiency Syndrome (AIDS) is caused by both types of Human Immunodeficiency Virus HIV-1 and HIV-2 and the majority of people infected with HIV-2 remain healthy for over 15 years. <br><br>The major goal of this work was to determine and describe genetic variants associated with phenotypic changes at the population level and study their role in pathogenesis and immune response. Studies presented in this thesis were carried out in two well established HIV-2 cohorts in Guinea Bissau and Gambia. Using recent tools in molecular medicine i.e. sequence-based techniques (SBT) (Chapter 2), we determined and comprehensively described variations at the two most polymorphic regions of the human genome: <i>HLA</i> and <i>KIR</i> gene complexes located on chromosomes 6 and 19, respectively, in these cohorts (Chapters 3 and 6). The data showed high heterogeneity in allele and genotype frequencies between the studied populations. Furthermore, we related the presence of gene variants to HIV-2 antibody status and study their effect on markers of disease progression, notably CD4<sup>+</sup> T cell count and viral load (Chapter 4). Here we showed for the first time that <i>HLA-B*1503</i> associates with poor prognosis after HIV-2 infection and <i>HLA-B*0801</i> with susceptibility to HIV-2 while the compound genotypes <i>KIR2DL2+HLA-C1</i> and <i>KIR2DS2+HLA-C1</i> protect against HIV-2 acquisition in the Manjako ethnic group. None of the HLA class I alleles/haplotypes and <i>KIR</i> gene profiles was found to influence HIV-2 infection in the second cohort, which was of mixed ethnic origin (Chapter 5). <br><br>In general, we observed that alleles previously shown to be associated with HIV-1 disease in western populations showed no effect in HIV-2 infection. This emphasizes the need to study <i>HLA</i> and <i>HLA/KIR</i> combinations in different populations in order to better inform subsequent vaccine design and evaluation in target populations.
In text/plain format

Archived Files and Locations

application/pdf  10.1 MB
file_um6k4bo4wfhy3ppfu5w6c7mu5y
oro.open.ac.uk (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   2010
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 08c05eb3-95b9-4d4f-9e2b-97367f455365
API URL: JSON